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Recent studies have shown the involvement of the sensory nervous system in patients 
with amyotrophic lateral sclerosis (ALS). The aim of our study was to investigate the 
correlation between the laryngeal sensitivity deficit and the type of ALS onset (bulbar or 
spinal) in a large series of 114 consecutive ALS patients. Participants were subdivided 
into two groups, bulbar and spinal ALS, according to the clinical onset of disease and 
submitted to a clinical and instrumental evaluation of swallowing, including a fiber-optic 
endoscopic evaluation of swallowing with sensory testing. Dysphagia severity was 
scored using the Penetration–Aspiration Scale (PAS) and the Pooling score (P-score). 
In addition, three patients with laryngeal sensitivity deficit were submitted to a laryngeal 
biopsy to assess the status of the sensory innervation. All patients showed a normal 
glottal closure during phonation and volitional cough. Fifty-six subjects (49%), 14 spinal- 
and 42 bulbar-onset ALS, showed dysphagia at the first clinical observation (PAS score 
>1; P-score >5). Dysphagia resulted more frequently in bulbar-onset ALS (P < 0.01). 
Thirty-eight (33%) patients had a sensory deficit of the larynx. The sensory deficit of 
the larynx was significantly more frequent in bulbar-onset ALS (P < 0.01). The sensory 
deficit of the larynx among dysphagic patients was also significantly more frequent in 
bulbar-onset ALS (P = 0.02). Several abnormalities were found in all three subjects who 
underwent a laryngeal biopsy: in one patient, no intraepidermal fiber was found; in the 
other two, the fibers showed morphological changes. Our observations are important to 
consider for assessment and management of dysphagia in patients with ALS.
Keywords: larynx, amyotrophic lateral sclerosis, deglutition disorders, sensory nerve endings, PgP 9.5
inTrODUcTiOn
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease causing progressive physical 
disabilities due to deficits of the motor nervous system. The upper and lower motor neurons are 
primarily affected, but involvement of the sensory nervous system has also been reported (1). In a 
multicentre, large electrophysiological study on 88 patients with ALS, abnormalities in the sensory 
nerve conduction parameters were found in 22.7% of the subjects (2). Sensory involvement in 32% 
of 103 ALS patients was also found in another electrophysiological study and confirmed by evidence 
of sensory nerve pathology in 91% of the 22 patients additionally subjected to sural-nerve biopsy (3). 
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In recent years, immunohistochemistry, by means of a selective 
pan neuronal marker used to highlight peripheral nerve tissue, 
the pan-axonal anti-protein-gene-product 9.5 (PGP 9.5), has 
emerged as a valuable tool to analyze sensory and autonomic 
innervation (4–6). Using this immunohistochemical technique, 
a significant reduction was found in epidermal nerve fiber density 
in the distal calf of 28 patients with ALS, supporting the concept 
of distal axonopathy in ALS (1). In a recent study, skin biopsies 
taken both from the thigh and from the distal leg of ALS patients 
disclosed normal intraepidermal nerve fiber density (INFD) in 
patients with bulbar onset, and a reduced INFD in patients with 
spinal onset (7). Sensorial deficits were recently found also at 
the laryngeal level. In a study on swallowing function in ALS, 
performed by means of fiber-optic endoscopic evaluation of 
swallowing (FEES) with sensory testing, abnormal sensation 
was found in 54.5% of the 22 tested patients (8). In a study on 
prevalence of dysphagia in ALS, an impaired laryngeal adduction 
reflex (LAR) resulted in 20.4% of the 49 ALS patients studied (9). 
Although the major factor causing swallowing troubles in ALS 
patients is the tongue muscle deficit, which correlates with pool-
ing and penetration (9), the abnormal sensation of the larynx 
can be regarded as a crucial factor in worsening dysphagia, as 
it reduces the efficacy of the LAR, consequently decreasing lung 
protection. The LAR, a brief closure of the true vocal folds, is 
a sensorimotor response that plays a key role in defending the 
lower airways during swallowing and protecting the larynx from 
food or fluid aspiration during premature spillage of material 
from the oral cavity or post-swallow inspiration. By contrast 
with the reflex control of breathing, volitional cough is probably 
mediated through corticobulbar pathways. The upper and lower 
motor neuron contribution to various respiratory muscles can be 
assessed neurophysiologically using magnetic stimulation of the 
motor cortex and spinal roots (10).
The aim of our study was to investigate the correlations 
between laryngeal sensitivity deficit and the type of ALS onset 
(bulbar or spinal) in a large series of ALS patients. In addition, 
three patients with laryngeal sensitivity deficit were submitted to 
laryngeal biopsy to assess directly the condition of the sensory 
innervation. The laryngeal biopsies were obtained during the 
tracheostomy performed for severe respiratory failures. The find-
ing of a correlation between the sensitivity of the larynx and the 
type of ALS could shed new light on the pathophysiology of ALS 
and could have potential implications on clinical diagnosis and 
on the treatment of dysphagia.
MaTerials anD MeThODs
A total of 114 ALS patients, diagnosed according to the El 
Escorial criteria at the ALS Center, Department of Neurology and 
Psychiatry, Umberto I Hospital, University of Rome “Sapienza,” 
were enrolled retrospectively. The study sample comprised 42 
women and 72 men (mean age 64 ± 10 years, range 42–82 years). 
Bulbar onset was reported in 56 patients and spinal onset in 58 
patients. The mean ages of the two groups were similar (66.2 ± 8.6 
in bulbar, 61.5 ± 9.9 in spinal ALS).
All patients were submitted to a clinical and instrumental 
evaluation of swallowing at the first admission into the ALS 
Center, by means of FEES, using a 3.7-mm diameter flexible fiber-
optic rhinolaryngoscope (Storz 11101). Dysphagia, if present, 
was classified as “oral,” “pharyngeal,” or both (“oropharyngeal”). 
The study of laryngeal sensitivity was based on lightly touching 
the pharyngeal walls, the laryngeal surface of the epiglottis, the 
aryepiglottic folds, or the arytenoids, using the tip of the probe 
according to the Langmore protocol (11). Laryngeal sensitivity 
was judged as pathologic when touching the epiglottis failed to 
trigger the LAR (12). Finally, to verify the functionality of the 
laryngeal adductor muscles, all the subjects were requested to 
phonate the vowel “i” and to voluntarily cough throughout a 
fiber-optic examination. Dysphagia severity was classified both 
according to aspiration events with the Penetration–Aspiration 
Scale (PAS) (13) and considering the amount and the ability to 
control residue/bolus pooling using the Pooling score (P-score) 
(14). Clinical assessment was also conducted with the revised 
ALS Functional Rating Scale (ALSFRS-R), a validated measure of 
functional impairment in ALS (15) containing 12 questionnaire-
based items rated from 0 (complete dependence for that function) 
to 4 (normal function), divided into three subscores (bulbar 12, 
motor 24, and respiratory 12), with normal function defined by 
a score of 48. Muscle strength of lower limbs was assessed with 
the Medical Research Council (MRC) scale for grading muscle 
strength, ranging from 0 (absence of movement) to 5 (contrac-
tion against full resistance), that quantifies muscle weakness in 
isolated muscles or muscle groups (16). In the MRC test, eight 
muscle groups in upper limbs and seven muscle groups in lower 
limbs are tested. The maximum scores are 40 for each upper limb 
and 35 for each lower limb.
Furthermore, in three subjects in whom FEES failed to elicit 
the LAR, an epiglottis biopsy specimen was also excised, imme-
diately after tracheotomy, under general anesthesia, by means of 
microlaryngoscopy. Samples were fixed overnight in Zamboni’s 
solution and cryoprotected in 20% sucrose phosphate-buffered 
saline solution, cut into 50-μm-thick sections on a freezing 
slide microtome (Leica 2000R; Leica Microsystems, Wetzlar, 
Germany). Three sections randomly chosen from each biopsy 
were immunoassayed with polyclonal anti-PGP 9.5 antibodies 
(1:1000; Biogenesis), using a free-floating protocol for bright-
field immunohistochemistry. The linear density of the intraepite-
lial nerve fibers was calculated according to the guidelines of 
the European Federation of Neurological Societies/Peripheral 
Nerve Society (17). Skin biopsy results were compared with the 
values found in our previous study on nerve endings in human 
laryngeal mucosa (12). The study was performed according to 
the ethical standards laid down in the Declaration of Helsinki, 
written informed consent was obtained from all research 
participants.
statistical analysis
Summary statistics are presented as frequencies and percentages, 
mean ± SD. The Yates-corrected chi-square test was used to com-
pare qualitative values. A t-test was used to compare means in 
normal groups. Statistical significance was accepted at P < 0.05. 
The delay between the onset of symptoms and the beginning of 
dysphagia at the date of last follow-up was measured with Cox’s 
F-test.
TaBle 2 | impairment of the swallowing phases detected by Fees in 
bulbar and spinal als patients.
Oral Pharyngeal Oral + pharyngeal Total
Bulbar 8 (12%) 0 (0%) 40 (61%) 48 (73%)
Spinal 14 (21%) 0 (0%) 4 (6%) 18 (27%)
Total 22 (33%) 0 (0%) 44 (67%) 66
TaBle 1 | als patients with or without dysphagia at baseline according 
to the spinal or bulbar onset.
Bulbar spinal Total
Dysphagia 48 (42%) 18 (16%) 66 (58%)
No dysphagia 8 (7%) 40 (35%) 48 (42%)
Total 56 (49%) 58 (51%) 114
The results are expressed as absolute numbers and percentages. Dysphagia was 
evaluated by PAS score >1 and P-score >5.
FigUre 1 | The delay between the onset of symptoms and beginning 
of dysphagia in spinal and bulbar als (months).
TaBle 3 | laryngeal sensitivity in relation to als onset.
Bulbar spinal Total
Laryngeal sensory deficit 34 (30%) 4 (4%) 38 (33%)
Normal laryngeal sensitivity 22 (19%) 54 (47%) 76 (67%)
Total 56 (49%) 58 (51%) 114
Laryngeal sensitivity was considered abnormal when the laryngeal adductor reflex 
(LAR) was not triggered with the touch of the epiglottis. All patients with abnormal LAR 
were dysphagic.
TaBle 4 | clinical and instrumental variables in the two groups, with 
normal laryngeal sensitivity and laryngeal sensory deficit.
laryngeal 
sensitivity  
deficit
normal  
laryngeal 
sensitivity
P
Age 67 ± 10 63 ± 10 ns
Delay between the onset of ALS 
symptoms and clinical observation
11 ± 7 15 ± 7.5 ns
ALSFRS 37 ± 8 38 ± 7.8 ns
PAS 6 ± 2.4 2 ± 1.8 <0.01
P-score 8.6 ± 2.2 5 ± 2 <0.01
FVC 2.3 ± 1 3 ± 1 ns
FEV1 1.9 ± 0.9 3.1 ± 2.5 ns
FEV1/FVC 79 ± 24 85 ± 10 ns
MRC 137 ± 12 127 ± 28 ns
The results are expressed as mean and SD.
ns, not significant; FVC, forced vital capacity; FEV1, forced expiratory volume at one 
second; FEV1/FVC, Tiffeneau index.
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resUlTs
All the clinical and instrumental examinations were performed 
14 ± 7.5 months after clinical onset (range 1–36 months). The 
delays between the onset of symptoms and the inclusion in the 
study were similar in both the spinal- and bulbar-onset ALS 
patient groups (12 ± 6.6 months in bulbar ALS, 12.2 ± 8 months 
in spinal ALS). Overall, the PAS score, the P-score and the 
ALSFRS-R score were respectively 4.7 ± 2.6, 8 ± 2.3, and 39 ± 6.2. 
All the patients showed a normal glottal closure during phona-
tion and volitional cough.
Sixty-six subjects (58%; 18 spinal and 48 bulbar) showed dys-
phagia at the first clinical observation (PAS score >1; P-score >5). 
Dysphagia was more frequent in bulbar-onset ALS (P <  0.01) 
(Table  1). PAS score and P-score were significantly higher in 
bulbar-onset ALS (PAS score = 4.8 ± 2.6; P-score = 8 ± 2.3) than 
in spinal onset (PAS score = 1.8 ± 1.5; P-score = 5 ± 2) (P < 0.01). 
The impairment of both swallowing phases detected by FEES was 
more frequent in bulbar ALS (P <  0.01): 40 of the 44 subjects 
with oropharyngeal dysphagia had bulbar-onset ALS (Table 2). 
No patient showed, exclusively, impairment of pharyngeal phase. 
At the retrospective analysis, the onset and the evolution of dys-
phagia were different in the bulbar and spinal groups (F = 6.6; 
P < 0.01) (Figure 1).
Of the 114 patients enrolled, 38 subjects (33%) had a larynx 
sensory deficit: 34 had bulbar ALS, while 4 had spinal onset 
(Table  3). The sensory deficit of the larynx was significantly 
more frequent in bulbar ALS (P <  0.01). All patients with a 
larynx sensory deficit were also dysphagic: among the 56 patients 
with dysphagia, 38 subjects (68%) showed abnormal laryngeal 
sensitivity, while 18 (32%) had normal sensitivity of the larynx. 
The sensory deficit of the larynx among dysphagic patients was 
significantly more frequent in bulbar ALS (P = 0.02). Specifically, 
34 of the 38 subjects with dysphagia and abnormal laryngeal sen-
sitivity had bulbar ALS, while only 4 had spinal onset. The clinical 
and instrumental characteristics of the two groups, normal and 
abnormal laryngeal sensitivity, are reported in Table 4.
The ALSFRS scores were similar between the two groups, 
with slightly lower values for the group with a sensory deficit of 
the larynx (37 ± 8 vs. 38 ± 7.8). The PAS scores were different 
between the two groups: the group with laryngeal sensory deficit 
had higher scores than the normal sensory group (6 ±  2.4 vs. 
2 ± 1.8; P < 0.01). The P-scores were also significantly different 
between the two groups, with higher scores for the group with 
a sensory deficit of the larynx (8.6 ± 2.1 vs. 6 ± 1.1; P < 0.01). 
Patients without laryngeal sensory deficits were more likely 
to have dysphagia involving only the oral phases (18 of the 22 
patients with impairment of the oral phases showed a normal 
laryngeal sensitivity), while patients with sensory deficits of the 
larynx were more likely to display oropharyngeal dysphagia (34 
of the 44 with an impairment in both the phases of swallowing 
showed a laryngeal sensory deficit).
FigUre 2 | Mucosa biopsy section from the epiglottis site of a control 
subject (red arrows show nerve fibers; red dotted lines indicate the 
junction between epithelium and lamina propria) (a), of the first als 
patient (showing the lack of intraepithelial fibers in the entire 
thickness of the epithelium) (B), of the second als patient (showing 
an increased and chaotic nerve branching not crossing the whole 
epithelium) (c), and of the third als patient (showing large axonal 
swellings in many branches of the intraepithelial fibers) (D). In the 
enlarged image (e), yellow arrows point to the axonal swelling. All three ALS 
patients were dysphagic and had a laryngeal sensory deficit. Bright-field 
immunohistochemistry with polyclonal PGP 9.5 antibody. Original 
magnification 40×.
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With regard to the subjective symptoms of dysphagia, 52 
patients (46%) reported swallowing problems at the first admis-
sion into the ALS Center, confirmed by a PAS score >1 and a 
P-score ≥6. Sixty-two patients (54%) did not refer dysphagia. In 
58 of them, normal swallowing was confirmed by a PAS score = 1 
and a P-score ≤5, while in 4, the swallowing examination showed 
an impairment of the oral phases of swallowing (PAS score >1 
and P-score ≤5), with a larynx sensory deficit in 2.
All three patients who underwent a laryngeal biopsy were dys-
phagic and had a laryngeal sensory deficit. Several abnormalities 
were found in all three subjects compared to the control subject 
(Figure 2): in the first patient, no intraepithelial fibers were found 
(Figure 2B vs. Figure 2A); in the other two patients, the number 
of fibers (respectively, 1.2 and 0.9/mm) was in the range of den-
sity obtained in our previous observations on normal subjects 
(0.83 ± 0.51/mm) (12), but the fibers showed clear morphological 
changes. In the second patient, the nerve branching was increased 
and chaotic; moreover, the fibers did not cross the whole epithe-
lium (Figure 2C vs. Figure 2A). In the third patient, we observed 
large axonal swellings in many branches of the intraepithelial 
fibers (Figures 2D,E vs. Figure 2A).
DiscUssiOn
In our study, a sensory deficit of the larynx was found in 33% of 
ALS patients, by means of the sensitivity test performed during 
FEES. The sensory deficits of the larynx were significantly more 
frequent in subjects with bulbar-onset ALS than in patients with 
spinal onset. All the patients of our sample showed a normal glot-
tal closure during phonation and volitional cough, thus assuring 
us that the failure in LAR triggering was not related to a motor 
deficit. In three patients, the presence of a sensory deficit at the 
laryngeal level was also confirmed by laryngeal biopsies performed 
during tracheostomy. While in one patient, no intraepithelial 
fiber was found, the other two showed morphological changes, 
such as increased branching and axonal swellings. Axonal swell-
ings have been described either quantitatively as enlargements 
above 1.5 μm (18) or semiquantitatively as enlargements more 
than twice the diameter of the parent fiber (19, 20). This finding is 
most commonly considered a predegenerative change. Increasing 
branching and axonal swellings have been frequently observed 
in patients with neuropathy and might represent an early sign of 
nerve fiber dysfunction (21, 22).
Dysphagia (PAS score >1; P-score >5) was found in 56 
subjects (49%), and it was significantly more frequent in subjects 
with bulbar-onset ALS. The onset of symptoms was reported by 
the patients and/or caregivers and could be underestimated due 
to the patients’ ability to adapt to the difficulties in swallowing. 
As expected, a large number (68%) of dysphagic ALS subjects 
displayed also a deficit of laryngeal sensitivity, and all the sub-
jects with a laryngeal sensitivity deficit were also dysphagic. 
The sensory deficit of the larynx among dysphagic patients was 
observed significantly more frequently in bulbar ALS. However, 
about one-third of the dysphagic subjects (32%) showed a normal 
LAR. These data are probably due to the peculiar progression of 
swallowing deficits in ALS patients, involving the oral phases ear-
lier. In our sample, the impairment of the pharyngeal phase was 
always observed in association with a deficit of the oral phases, 
and 89% of dysphagic patients with laryngeal sensory deficits 
displayed dysphagia involving also the pharyngeal phase. In our 
opinion, in ALS patients, already suffering from oropharyngeal or 
pharyngeal dysphagia due to the reduced muscular efficiency of 
the tongue base and of the pharynx, the sensorial failure in trig-
gering the LAR could be responsible for a further worsening of 
the pharyngeal phase of swallowing. At present, however, sensory 
deficits are not specifically described in swallowing scales and the 
classification of the dysphagia severity releases only on the level 
of bolus penetration, according to the widely accepted PAS (13).
Our data are consistent with several previous studies suggest-
ing that ALS is a neurodegenerative pathology not confined to 
motor neurons but also affecting sensory neurons. In a previous 
study, we showed that, in patients with spinal-onset ALS, distal 
INFD at the skin biopsy of the leg was reduced. Conversely, in 
patients with bulbar-onset ALS, skin biopsy of the leg disclosed 
normal INFD (7). Sensory involvement in ALS patients has been 
demonstrated by means of subjective descriptions, electrophysi-
ological recordings, and pathologic studies (1–7). In particular, 
Weis et al. (1), exploring the prevalence of small fiber neuropathy 
in ALS patients with the same immunohistochemical technique 
we used, found a significant reduction of INFD in the distal calf 
of ALS patients, whereas proximal epidermal nerve fibers were at 
the lower end of the normal range of values reported for normal 
controls. In our previous study on small fiber neuropathy in ALS 
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patients, a reduction of the distal INFD was found in subjects 
with spinal onset. Also abnormal laryngeal sensation was previ-
ously found in two studies by means of clinical assessment (8, 
9). In our population, the group with laryngeal sensory deficit 
showed higher PAS scores, consistent with the increased dif-
ficulty to eject the material from the airway. The P-score values 
also indicated pathology, demonstrating the difficulties of ALS 
patients with laryngeal sensory deficit to handle the pooling in 
the hypopharynx.
The interaction of the motor and sensory deficits at the level of 
the aerodigestive crossroad is a serious condition that increases 
the risk of pneumonia, thus confirming the need for a detailed 
diagnostic instrumental workup to evaluate dysphagia. In par-
ticular, if the prevention of aspiration is no longer assured by 
the compensatory strategies, such as consistency modifications 
of foods and liquids and postures, the patient should undergo 
percutaneous endoscopic gastrostomy or radiologically inserted 
gastrostomy in accordance with the most recent European guide-
lines (23). Furthermore, from a clinical point of view, our data on 
laryngeal sensory deficits support FEES as the method of choice 
for swallowing evaluation in ALS subjects. Even if videofluoros-
copy is more accurate in identifying subtle abnormalities in the 
pharyngeal phase of swallowing, FEES allows the assessment of 
the laryngeal sensitivity so critical in deciding the management 
of dysphagic patients. Furthermore, endoscopic examination is 
easy to perform, also at the ALS Center, avoiding patient dis-
comfort, and it is repeatable at each subsequent control. In ALS, 
as in other neurodegenerative pathologies, the early detection 
of silent aspiration is critical to prevent such serious complica-
tions as pulmonary infections and malnutrition. In our sample, 
4 out of the 62 patients who did not report swallowing problems 
showed abnormalities in the oral phases or sensitivity deficit of 
the larynx.
A limitation of our study is the small number of subjects avail-
able to undergo a laryngeal biopsy. Apart from the unwillingness 
of some patients to provide informed consent, this is due to the 
poor health conditions of the majority of ALS patients facing 
tracheotomy that usually discourage performing a subsequent 
laryngeal biopsy under microlaryngoscopy.
In conclusion, data from our study support sensory involve-
ment in ALS patients. Sensory deficits at the level of the larynx 
were significantly more frequent in bulbar ALS. In three dysphagic 
ALS patients with a laryngeal sensory involvement, a biopsy of 
the laryngeal mucosa, showing in one subject no intraepithelial 
fiber and morphological changes in these fibers in the other two 
patients, allowed us to confirm the presence of a sensory deficit 
at the laryngeal level. All the patients with a deficit in laryngeal 
sensitivity also had oropharyngeal dysphagia. The combination 
of motor and sensory deficits at the level of the oropharynx leads 
to a serious dysphagia with an increased risk of aspiration. In all 
ALS patients, an early and accurate diagnostic workup to evaluate 
dysphagia is needed. FEES is the method of choice, allowing also 
the assessment of laryngeal sensitivity.
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